rss
J Neurol Neurosurg Psychiatry 1994;57:164-168 doi:10.1136/jnnp.57.2.164
  • Research Article

A placebo-controlled trial of isoprinosine in patients with multiple sclerosis.

  1. N M Milligan,
  2. D H Miller,
  3. D A Compston
  1. Department of Neurology, University Hospital of Wales, Heath Park, Cardiff, UK.

      Abstract

      Isoprinosine was used under double-blind, randomised, and placebo-controlled conditions in 52 patients with relapsing/remitting or progressive multiple sclerosis. All patients received pulsed treatment with methylprednisolone. There was no significant effect of treatment on clinical disability or the accumulation of MRI abnormalities, after correction of results for multiple comparisons. It is concluded that isoprinosine is not effective therapy for multiple sclerosis.

      This Article

      1. Abstract
      2. PDF

      Responses

      1. Submit a response
      2. No responses published

      Register for free content

      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

      BMJ Careers - Latest neurology and neurosurgery jobs